<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7498411\results\search\testTrace\results.xml">
  <result pre="the search for effective antiviral drugs as well as therapeutic" exact="treatment" post="options. The shortcomings of existing antiviral agents such as"/>
  <result pre="syndrome (SARS) outbreak in 2003 induced 774 deaths and 8096" exact="infection" post="cases [4], and its economic cost was estimated to"/>
  <result pre="a SARS vaccine or combinatorial antiretroviral therapy (cART) in the" exact="treatment" post="of HIV [7,8]. Nevertheless, up to 2016, only 90"/>
  <result pre="2016, only 90 antiviral drugs had been approved for the" exact="treatment" post="of 9 types of human transmissible diseases, namely HIV,"/>
  <result pre="new antiviral drugs, vaccines, and antibodies are powerful prevention and" exact="treatment" post="strategies for viral infections, most of these selectively target"/>
  <result pre="our recent study revealed that AgNPs could block the primary" exact="infection" post="of Kaposiâ€™s sarcoma-associated herpesvirus (KSHV) by directly destroying its"/>
  <result pre="acyclovir can be used to treat herpes simplex virus (HSV)" exact="infection" post="through disruption of the viral DNA polymerase function by"/>
  <result pre="ultimately improve antibody levels and immune response to the HCV" exact="infection" post="in immunized mice [27]. Furthermore, nanovaccines based on genetic"/>
  <result pre="of antiviral nanoagents, but also a better understanding of the" exact="infection" post="mechanisms, especially for viruses exhibiting a high mutation rate"/>
  <result pre="of innate and adaptive immunity, should be clarified. (iv)A viral" exact="infection" post="involves the following stages: attachment to membrane receptors, penetration"/>
  <result pre="that can inhibit the abovementioned processes. Furthermore, the prediction and" exact="screening" post="of the interactions between ENMs and viruses during the"/>
  <result pre="screening of the interactions between ENMs and viruses during the" exact="infection" post="process requires more powerful and high-throughput analytical platforms. (v)The"/>
  <result pre="antiviral nanoagents to lesions is an important concern during the" exact="treatment" post="of diverse viruses. Generally, intravenous administration may be the"/>
  <result pre="the most commonly used clinical route, especially for treating an" exact="infection" post="due to influenza virus. However, for gastrointestinal infections caused"/>
 </snippets>
</snippetsTree>
